Nektar Therapeutics - Company Profile
Powered by
All the data and insights you need on Nektar Therapeutics in one report.
$295
- Save hours of research time and resources with
our up-to-date Nektar Therapeutics Strategy Report
- Understand Nektar Therapeutics position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Nektar Therapeutics patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
US11419943B2 | Grant | Polymer-sunitinib conjugates | A61K31/404; A61K47/58; A61K47/60 | August 23, 2022 |
KR102432169B1 | Grant | -15 CONJUGATES OF AN IL-15 MOIETY AND A POLYMER | A61K38/2086; A61K47/00; A61K47/60; A61P35/00; A61P35/04; A61P43/00; C08G65/34; C08G65/48 | August 11, 2022 |
US11406618B2 | Grant | Polymer-des-ethyl sunitinib conjugates | A61K31/404; A61K47/60 | August 09, 2022 |
US20220235056A1 | Application | ADENOSINE 2 RECEPTOR ANTAGONISTS | C07B2200/05; C07D487/04; C07D519/00 | July 28, 2022 |
NL301184I2 | Grant | rurioctocog alfa pegol | A61K38/37; A61K38/38; A61K47/10; A61K47/50; A61K47/60; A61P7/00; A61P7/04; A61P7/06 | July 21, 2022 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer